[31] showed that IGF2BP2 mediates the nuclear localization of p65 and promotes hepatocellular carcinoma (HCC) metastasis through the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)/ Zinc finger E-box binding homeobox 1 (ZEB1) axis, an independent indicator of HCC. Here, IGF2BP2 is linked to hepatocellular carcinoma.